Efficacy and safety of Siponimod (BAF312) in SPMS patients

Mayzent is an oral treatment for relapse remitting MS and active secondary progressive MS.
Post Reply
User avatar
seeva
Family Elder
Posts: 511
Joined: Sun Jan 20, 2008 3:00 pm
Location: SYDNEY
Contact:
Contact seeva

Efficacy and safety of Siponimod (BAF312) in SPMS patients

Post by seeva »

http://www.mstrials.org.au/multicenter- ... uration-st
HI friends this trial's recruiting people with SPMS for the trial in sydney hospitals until may 2014 more details read the website
regards
seeva
Top
Post Reply

Return to “Mayzent (Siponimod)”